Neurocrine Biosciences (NBIX) Inventory (2017 - 2026)
Neurocrine Biosciences' Inventory was $66.1 million in Q3 2026, down 4.6% from $69.3 million a year earlier and down 36.6% from the prior quarter.
Powered by 
Analysis
Neurocrine Biosciences (NBIX) Inventory (2017 - 2026) Analysis & Trends
At the end of FY2025, Inventory at Neurocrine Biosciences came in at $69 million, up 20.2% from FY2024.
- Inventory has now increased for eight consecutive years, with a five-year compound annual growth rate of 19.8% (FY2020 to FY2025).
- In earlier years, Inventory was $57.4 million in FY2024 (+49.9%), $38.3 million in FY2023 (+9.1%), $35.1 million in FY2022 (+15.1%) and $30.5 million in FY2021 (+8.9%).
- Quarterly Inventory has moved between $28.8 million (Q3 2023) and $104.2 million (Q2 2026) over five years.
- Compared with a year earlier, Inventory was higher in seven of the last eight quarters, with growth averaging 37.7%.
- The best year-over-year quarter for Inventory over five years was Q2 2026 (growth of 83.1%); the worst was Q3 2023 (a decline of 22.2%).
- Per Business Quant data, NBIX's Inventory in the three quarters before Q3 2026 was $104.2 million (Q2 2026), $64.5 million (Q1 2026) and $69 million (Q4 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Inventory (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,348.13 Bn | 1,321.74 Bn | 20.46 Bn | 18.19 Bn |
| 2 | Johnson & Johnson | 675.90 Bn | 595.76 Bn | 17.30 Bn | 15.38 Bn |
| 3 | AbbVie | 519.45 Bn | 487.50 Bn | 13.12 Bn | 5.31 Bn |
| 4 | Merck | 364.95 Bn | 327.95 Bn | 13.19 Bn | 6.16 Bn |
| 5 | Novartis Ag | 311.58 Bn | 285.16 Bn | - | - |
| 6 | Astrazeneca | 289.34 Bn | 262.94 Bn | 13.26 Bn | 6.88 Bn |
| 7 | Amgen | 251.64 Bn | 203.30 Bn | 7.58 Bn | 6.39 Bn |
| 8 | Gilead Sciences | 212.05 Bn | 187.07 Bn | 6.73 Bn | 1.90 Bn |
| 9 | Pfizer | 167.35 Bn | 115.00 Bn | 12.56 Bn | 10.02 Bn |
| 10 | Neurocrine Biosciences | 17.13 Bn | 13.21 Bn | 1.10 Bn | 66.10 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Sep 30, 2026 | 66.10 Mn |
| Jun 30, 2026 | 104.20 Mn |
| Mar 31, 2026 | 64.50 Mn |
| Dec 31, 2025 | 69.00 Mn |
| Sep 30, 2025 | 69.30 Mn |
| Jun 30, 2025 | 56.90 Mn |
| Mar 31, 2025 | 59.10 Mn |
| Dec 31, 2024 | 57.40 Mn |
| Sep 30, 2024 | 45.80 Mn |
| Jun 30, 2024 | 42.50 Mn |
| Mar 31, 2024 | 37.20 Mn |
| Dec 31, 2023 | 38.30 Mn |
| Sep 30, 2023 | 28.80 Mn |
| Jun 30, 2023 | 31.70 Mn |
| Mar 31, 2023 | 33.40 Mn |
| Dec 31, 2022 | 35.10 Mn |
| Sep 30, 2022 | 37.00 Mn |
| Jun 30, 2022 | 29.30 Mn |
| Mar 31, 2022 | 29.00 Mn |
| Dec 31, 2021 | 30.50 Mn |
API Access
Neurocrine Biosciences Inventory API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=inventory&ticker=NBIX&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "inventory", "ticker": "NBIX", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=inventory&ticker=NBIX&period=max&api_key=YOUR_API_KEY");
const data = await res.json();